One major reason for the high cost is that Zepbound is still under patent protection and market exclusivity, which block lower-cost generics from entering the market
Citicoline for the management of patients with traumatic brain injury in the acute phase: a systematic review and meta-analysis
What patients praise: Customer service quality is the most consistent positive
Wegovy (semaglutide 2.4 mg) Specifically FDA-approved for chronic weight management Once-weekly injection Indicated for patients with BMI 30, or 27 with comorbidities (e.g., hypertension, sleep apnea) 2
Wilson Tang, M.D., Zeneng Wang, Ph.D., Bruce S
There are no specific food restrictions, but a balanced, healthy diet is recommended to enhance weight loss results